Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec)

References

• Bernkop-Schnurch A. (1998). The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release 52:1–16
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A, Schmitz T. (2007). Presystemic metabolism of orally administered peptide drugs and strategies to overcome it. Curr Drug Metab 8:509–17
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, et al. (2006). Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release 114:242–50
   PubMed Web of Science ®Google Scholar
• des Rieux A, Fievez V, Garinot M, et al. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1–27
   PubMed Web of Science ®Google Scholar
• Desai P, Patlolla RR, Singh M. (2010). Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol 27:247–59
   PubMed Web of Science ®Google Scholar
• Du W, Fan Y, Zheng N, et al. (2013). Transferrin receptor specific nanocarriers conjugated with functional 7 peptide for oral drug delivery. Biomaterials 34:794–806
   PubMed Web of Science ®Google Scholar
• Dupont E, Prochiantz A, Joliot A. (2007). Identification of a signal peptide for unconventional secretion. J Biol Chem 282:8994–9000
   PubMed Web of Science ®Google Scholar
• Fan T, Chen C, Guo H, et al. (2014). Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs. Eur J Pharm Biopharm 88:518–28
   PubMed Web of Science ®Google Scholar
• Farkhani SM, Valizadeh A, Karami H, et al. (2014). Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules. Peptides 57:78–94
   PubMed Web of Science ®Google Scholar
• Foged C, Nielsen HM. (2008). Cell-penetrating peptides for drug delivery across membrane barriers. Expert Opin Drug Deliv 5:105–17
   PubMed Web of Science ®Google Scholar
• Fonseca S, Pereira MP, Kelley SO. (2009). Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev 61:953–64
   PubMed Web of Science ®Google Scholar
• Futaki S. (2005). Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv Drug Deliv Rev 57:547–58
   PubMed Web of Science ®Google Scholar
• Futaki S, Suzuki T, Ohashi W, et al. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276:5836–40
   PubMed Web of Science ®Google Scholar
• Gamboa JM, Leong KW. (2013). In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv Drug Deliv Rev 65:800–10
   PubMed Web of Science ®Google Scholar
• Goldberg M, Gomez-Orellana I. (2003). Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2:289–95
   PubMed Web of Science ®Google Scholar
• Gupta V, Hwang BH, Doshi N, et al. (2013). A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine. J Control Release 172:541–9
   PubMed Web of Science ®Google Scholar
• Khalil IA, Kogure K, Futaki S, et al. (2007). Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther 14:682–9
   PubMed Web of Science ®Google Scholar
• Koch AM, Reynolds F, Merkle HP, et al. (2005). Transport of surface-modified nanoparticles through cell monolayers. Chembiochem 6:337–45
   PubMed Web of Science ®Google Scholar
• Koren E, Torchilin VP. (2012). Cell-penetrating peptides: breaking through to the other side. Trends Mol Med 18:385–93
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75:1–18
   PubMed Web of Science ®Google Scholar
• Lee JY, Choi YS, Suh JC, et al. (2011). Cell-penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy. Int J Cancer 128:2470–80
   PubMed Web of Science ®Google Scholar
• Liang JF, Yang VC. (2005). Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency. Biochem Biophys Res Commun 335:734–8
   PubMed Web of Science ®Google Scholar
• Liu BR, Liou JS, Chen YJ, et al. (2013a). Delivery of nucleic acids, proteins, and nanoparticles by arginine-rich cell-penetrating peptides in rotifers. Mar Biotechnol 15:584–95
   PubMed Web of Science ®Google Scholar
• Liu X, Liu C, Zhang W, et al. (2013b). Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin. Int J Pharm 448:159–67
   PubMed Web of Science ®Google Scholar
• Mahato RI, Narang AS, Thoma L, et al. (2003). Emerging trends in oral delivery of peptide and protein drugs. Crit Rev Ther Drug 20:153–214
   PubMed Web of Science ®Google Scholar
• Morishita M, Kamei N, Ehara J, et al. (2007). A novel approach using functional peptides for efficient intestinal absorption of insulin. J Control Release 118:177–84
   PubMed Web of Science ®Google Scholar
• Mussbach F, Franke M, Zoch A, et al. (2011). Transduction of peptides and proteins into live cells by cell penetrating peptides. J Cell Biochem 112:3824–33
   PubMed Web of Science ®Google Scholar
• Nakase I, Niwa M, Takeuchi T, et al. (2004). Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 10:1011–22
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–47
   PubMed Web of Science ®Google Scholar
• Patel L, Wang J, Kim KJ, et al. (2009). Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin. Mol Pharm 6:492–503
   PubMed Web of Science ®Google Scholar
• Patel L, Zaro JL, Shen WC. (2007). Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res 24:1977–92
   PubMed Web of Science ®Google Scholar
• Renukuntla J, Vadlapudi AD, Patel A, et al. (2013). Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 447:75–93
   PubMed Web of Science ®Google Scholar
• Ruan G, Agrawal A, Marcus AI, et al. (2007). Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J Am Chem Soc 129:14759–66
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, et al. (2002). Residual polyvinyl alcohol associated with poly(d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82:105–14
   PubMed Web of Science ®Google Scholar
• Sawant RM, Hurley JP, Salmaso S, et al. (2006). “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 17:943–9
   PubMed Web of Science ®Google Scholar
• Schwarze S, Ho A, Vocero-Akbani A, et al. (1999). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569–72
   PubMed Web of Science ®Google Scholar
• Sethuraman VA, Lee M, Bae YH. (2008). A biodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm Res 25:657–66
   PubMed Web of Science ®Google Scholar
• Sood A, Panchagnula R. (2001). Peroral route: an opportunity for protein and peptide drug delivery. Chem Rev 101:3275–303
   PubMed Web of Science ®Google Scholar
• Stewart KM, Horton KL, Kelley SO. (2008). Cell-penetrating peptides as delivery vehicles for biology and medicine. Org Biomol Chem 6:2242–55
   PubMed Web of Science ®Google Scholar
• Su FY, Lin KJ, Sonaje K, et al. (2012). Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Biomaterials 33:2801–11
   PubMed Web of Science ®Google Scholar
• Suzuki T, Futaki S, Niwa M, et al. (2002). Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 277:2437–43
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2008). Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev 60:548–58
   PubMed Web of Science ®Google Scholar
• Wang F, Wang Y, Zhang X, et al. (2014). Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. J Control Release 174:126–36
   PubMed Web of Science ®Google Scholar
• Xu Q, Boylan NJ, Cai S, et al. (2013). Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus. J Control Release 170:279–86
   PubMed Web of Science ®Google Scholar
• Yan L, Wang H, Jiang Y, et al. (2012). Cell-penetrating peptide-modified PLGA nanoparticles for enhanced nose-to-brain macromolecular delivery. Macromol Res 21:435–41
   Web of Science ®Google Scholar
• Yin Y, Chen D, Qiao M, et al. (2007). Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution. J Control Release 123:27–38
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Zhang YL, Zhou JP, et al. (2012). Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin. Int J Nanomed 7:3333–9
   PubMed Web of Science ®Google Scholar